Handelsbanken Fonder AB - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$160,000
-37.5%
28,0000.0%0.00%0.0%
Q4 2021$256,000
-14.4%
28,0000.0%0.00%
-50.0%
Q3 2021$299,000
-31.3%
28,0000.0%0.00%0.0%
Q2 2021$435,000
+23.6%
28,000
+29.0%
0.00%0.0%
Q1 2021$352,000
+28.0%
21,700
+66.9%
0.00%0.0%
Q4 2020$275,000
+42.5%
13,0000.0%0.00%
+100.0%
Q3 2020$193,000
-49.5%
13,000
-50.0%
0.00%
-50.0%
Q2 2020$382,00026,0000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders